Back to top

rsi: Archive

Zacks Equity Research

LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LFSTPositive Net Change

Zacks Equity Research

Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK)

PROKIDNEY CP (PROK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PROKPositive Net Change

Zacks Equity Research

Down -36.7% in 4 Weeks, Here's Why Frontier Group (ULCC) Looks Ripe for a Turnaround

Frontier Group (ULCC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ULCCPositive Net Change

Zacks Equity Research

Down -36.19% in 4 Weeks, Here's Why Asana (ASAN) Looks Ripe for a Turnaround

Asana (ASAN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ASANNegative Net Change

Zacks Equity Research

Down -34.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Stitch Fix (SFIX)

Stitch Fix (SFIX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SFIXNegative Net Change

Zacks Equity Research

Nkarta (NKTX) Loses -33.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Nkarta (NKTX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

NKTXNegative Net Change

Zacks Equity Research

After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals (CRBP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CRBPNegative Net Change

Zacks Equity Research

Here's Why FinWise Bancorp (FINW) is Poised for a Turnaround After Losing -15.71% in 4 Weeks

FinWise Bancorp (FINW) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

FINWNegative Net Change

Zacks Equity Research

Down -26.32% in 4 Weeks, Here's Why Duluth Holdings (DLTH) Looks Ripe for a Turnaround

Duluth Holdings (DLTH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

DLTHNegative Net Change

Zacks Equity Research

Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Nkarta (NKTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NKTXNegative Net Change

Zacks Equity Research

After Plunging -22.9% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals (CRBP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CRBPNegative Net Change

Zacks Equity Research

After Plunging -22.32% in 4 Weeks, Here's Why the Trend Might Reverse for Royal Caribbean (RCL)

The heavy selling pressure might have exhausted for Royal Caribbean (RCL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

RCLNegative Net Change

Zacks Equity Research

Down -54.85% in 4 Weeks, Here's Why Arvinas (ARVN) Looks Ripe for a Turnaround

Arvinas (ARVN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ARVNPositive Net Change

Zacks Equity Research

Reddit Inc. (RDDT) Loses -41.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Reddit Inc. (RDDT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

RDDTPositive Net Change

Zacks Equity Research

After Plunging -27.5% in 4 Weeks, Here's Why the Trend Might Reverse for Amplify Energy (AMPY)

Amplify Energy (AMPY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

AMPYPositive Net Change

Zacks Equity Research

Down -28.08% in 4 Weeks, Here's Why Remitly Global (RELY) Looks Ripe for a Turnaround

Remitly Global (RELY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

RELYPositive Net Change

Zacks Equity Research

Discover (DFS) Loses -21.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Discover (DFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

After Plunging -22.73% in 4 Weeks, Here's Why the Trend Might Reverse for Shimmick Corporation (SHIM)

Shimmick Corporation (SHIM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SHIMPositive Net Change

Zacks Equity Research

Down -29.44% in 4 Weeks, Here's Why You Should You Buy the Dip in OppFi (OPFI)

OppFi (OPFI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

OPFIPositive Net Change

Zacks Equity Research

Down -53.96% in 4 Weeks, Here's Why Arvinas (ARVN) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Arvinas (ARVN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ARVNPositive Net Change

Zacks Equity Research

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround

Supernus (SUPN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SUPNNegative Net Change

Zacks Equity Research

Down -35.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Marvell (MRVL)

Marvell (MRVL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

MRVLPositive Net Change

Zacks Equity Research

Down -8.49% in 4 Weeks, Here's Why Concentra (CON) Looks Ripe for a Turnaround

Concentra (CON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CONPositive Net Change

Zacks Equity Research

RingCentral (RNG) Loses -19.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for RingCentral (RNG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

RNGNegative Net Change

Zacks Equity Research

After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)

The heavy selling pressure might have exhausted for Ginkgo Bioworks (DNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

DNANegative Net Change